Citáce podľa APA (7th ed.)

de Vries Lentsch, S., Garrelds, I. M., Danser, A. H. J., Terwindt, G. M., & MaassenVanDenBrink, A. (2022). Serum CGRP in migraine patients using erenumab as preventive treatment. Journal of headache and pain, 23(1), 120-7. https://doi.org/10.1186/s10194-022-01483-z

Citácia podle Chicago (17th ed.)

de Vries Lentsch, Simone, Ingrid M. Garrelds, A. H. Jan Danser, Gisela M. Terwindt, a Antoinette MaassenVanDenBrink. "Serum CGRP in Migraine Patients Using Erenumab as Preventive Treatment." Journal of Headache and Pain 23, no. 1 (2022): 120-7. https://doi.org/10.1186/s10194-022-01483-z.

Citácia podľa MLA (8th ed.)

de Vries Lentsch, Simone, et al. "Serum CGRP in Migraine Patients Using Erenumab as Preventive Treatment." Journal of Headache and Pain, vol. 23, no. 1, 2022, pp. 120-7, https://doi.org/10.1186/s10194-022-01483-z.

Upozornenie: Tieto citáce sú generované automaticky. Nemusia byť úplne správne podľa citačných pravidiel..